Hui-rong Qian

4 Engineering Drive 4
Singapore, 117585, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Dulaglutide and neurodegeneration biomarkers: REWIND post hoc analysis.

Dulaglutide and neurodegeneration biomarkers: REWIND post hoc analysis.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 12, 2026

Objective criteria for statistical assessments of cross validation of bioanalytical methods.

Objective criteria for statistical assessments of cross validation of bioanalytical methods.

Journal: Bioanalysis

Published: October 28, 2025

Impact of tirzepatide treatment on participant-reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction.

Impact of tirzepatide treatment on participant-reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction.

Journal: Diabetes, obesity & metabolism

Published: June 17, 2025

LY3522348, A New Ketohexokinase Inhibitor: A First-in-Human Study in Healthy Adults.

LY3522348, A New Ketohexokinase Inhibitor: A First-in-Human Study in Healthy Adults.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: March 05, 2025

Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation.

Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation.

Journal: Cell metabolism

Published: August 07, 2024

Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis.

Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis.

Journal: Diabetes care

Published: December 09, 2022

Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide.

Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide.

Journal: American journal of nephrology

Published: November 22, 2022

Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease.

Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease.

Journal: Nature communications

Published: July 20, 2022

Genome-Wide Polygenic Score and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study.

Genome-Wide Polygenic Score and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study.

Journal: Circulation. Genomic and precision medicine

Published: January 04, 2020

Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients.

Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients.

Journal: Scientific reports

Published: January 15, 2019

Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.

Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.

Journal: Molecular neurodegeneration

Published: July 09, 2018

Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene.

Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene.

Journal: Cancer discovery

Published: April 30, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026